Longitudinal studies have demonstrated that patients with serum BDNF levels < 10 ng/mL have a 30% increased rate of annual decline in motor function (up to 30% as measured on the Unified Parkinson’s Disease Rating Scale scores) [171,172,173]. The gene discussed is BDNF; the disease is Parkinson disease.